BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $367,000 | -53.7% | 2,425 | -55.4% | 0.03% | -51.4% |
Q2 2022 | $792,000 | +23.0% | 5,435 | 0.0% | 0.07% | +48.9% |
Q1 2022 | $644,000 | -14.0% | 5,435 | 0.0% | 0.05% | -2.1% |
Q4 2021 | $749,000 | -24.9% | 5,435 | -24.4% | 0.05% | -34.2% |
Q3 2021 | $998,000 | +43.2% | 7,185 | 0.0% | 0.07% | +49.0% |
Q2 2021 | $697,000 | +42.0% | 7,185 | 0.0% | 0.05% | +28.9% |
Q1 2021 | $491,000 | -26.2% | 7,185 | -7.4% | 0.04% | -19.1% |
Q4 2020 | $665,000 | +38.3% | 7,760 | +4.9% | 0.05% | +23.7% |
Q3 2020 | $481,000 | -3.2% | 7,400 | +8.8% | 0.04% | -13.6% |
Q2 2020 | $497,000 | – | 6,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |